The Merger Fund INBX Holdings History

Number of Shares
198,509.00
Current Holdings Value*
$223,320.00
% of Portfolio
0.01%
Total Estimate Gain
$269.39 Mil
% of Total Estimate Gain
37.81%

The Merger Fund's Inhibrx Biosciences Inc Holding Summary

As of 2025-03-31, The Merger Fund held 198,509.00 shares of Inhibrx Biosciences Inc(INBX), totaling $223,320.00. This investment constitutes 0.01% of their stock portfolio, and The Merger Fund now holds 1.37% of the outstanding Inhibrx Biosciences Inc(INBX) stock.

The initial trade took place in 2024Q2. And since then The Merger Fund has made 3 purchases of INBX, at an average price of $13.82, for a total of 51.54 Mil shares. In addition, there have been 1 sales at an average price of $15.23 for 25.74 Mil shares. Based on historical transaction data and INBX's current price of $22.86, The Merger Fund's estimated gain on his INBX holdings is $269.39 Mil, reflecting a 37.81% gain to date.

The Merger Fund INBX ($22.86) Holding Chart

The Merger Fund INBX ($22.86) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1